Belgium· BE-AMP-SAM136245-00
Telebrix 35 350 mg I/ml
A ioxitalaminsäure product containing ioxitalamate meglumine, registered in Belgium by Guerbet. The same ATC class is registered in 5 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Ioxitalaminsäure is registered in 5 of 19 countries.
Countries holding a registration under ATC V08AA05 (ioxitalaminsäure), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 4 of them publish a price we can compare per daily dose
Ioxitalaminsäure · ATC V08AA05
5 / 19 countries
- Belgiumprice
- Czechiaprice
- Netherlands
- Norwayprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Ioxitalamate Meglumine
- Manufacturer
- Guerbet
- Country
- Belgium (BE)
- ATC code
- V08AA05
- ATC class
- Ioxitalaminsäure
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0600312
- be_apb0730473
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ioxitalaminsäure in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyTelebrix GastroGuerbet
- CzechiaTELEBRIX GASTROGuerbet, Roissy CdG Cedex
- FranceTELEBRIX GASTRO (300 mg l/mL), solution pour administration par voie orale ou rectaleGUERBET
- NorwayTelebrix GastroGuerbet
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Czechia · Telebrix Gastro
- Germany · Telebrix Gastro
- France · Telebrix Gastro
- Hungary · Telebrix Gastro
- Luxembourg · Telebrix Gastro
- Netherlands · Telebrix Gastro
- Portugal · Telebrix Gastro
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7dcf748d-db3a-4fd4-9aeb-226be5c2d24a GET /v1/drugs/7dcf748d-db3a-4fd4-9aeb-226be5c2d24a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "REVOKED",
"name_en": "Telebrix 35 350 mg I/ml",
"name_fr": "Telebrix 35 350 mg I/ml",
"name_nl": "Telebrix 35 350 mg I/ml",
"amp_code": "SAM136245-00",
"strengths": [
"650.9000",
"650.9000",
"592.9000",
"592.9000",
"96.6000",
"96.6000",
"592.9000",
"592.9000"
],
"pack_count": 1,
"substances": [
"Ioxitalamate Meglumine",
"Ioxitalamic Acid",
"Ioxitalamate Sodium"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Ioxitalamic Acid",
"authorisation_numbers": [
"BE136245"
]
}See everything about ioxitalaminsäure.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.